Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
1998-6-2
|
pubmed:abstractText |
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and a key mediator of aberrant endothelial cell proliferation and vascular permeability in a variety of human pathological situations such as tumor angiogenesis, diabetic retinopathy, or psoriasis. By amino-terminal deletion analysis and by site-directed mutagenesis we have identified a new domain within the amino-terminal alpha-helix that is essential for dimerization of VEGF. VEGF121 variants containing amino acids 8 to 121 or 14 to 121, respectively, either expressed in Escherichia coli and refolded in vitro, or expressed in Chinese hamster ovary cells, were in a dimeric conformation and showed full binding activity to VEGF receptors and stimulation of endothelial cell proliferation as compared with wild-type VEGF. In contrast, a VEGF121 variant covering amino acids 18 to 121, as well as a variant in which the hydrophobic amino acids Val14, Val15, Phe17, and Met18 within the amphipathic alpha-helix near the amino terminus were replaced by serine, failed to form biological active VEGF dimers. From these data we conclude that a domain between amino acids His12 and Asp19 within the amino-terminal alpha-helix is essential for formation of VEGF dimers, and we propose hydrophobic interactions between VEGF monomers to stabilize or favor dimerization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
273
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11115-20
|
pubmed:dateRevised |
2007-5-2
|
pubmed:meshHeading |
pubmed-meshheading:9556597-Amino Acid Sequence,
pubmed-meshheading:9556597-Amino Acid Substitution,
pubmed-meshheading:9556597-Animals,
pubmed-meshheading:9556597-CHO Cells,
pubmed-meshheading:9556597-Cricetinae,
pubmed-meshheading:9556597-Dimerization,
pubmed-meshheading:9556597-Endothelial Growth Factors,
pubmed-meshheading:9556597-Escherichia coli,
pubmed-meshheading:9556597-Lymphokines,
pubmed-meshheading:9556597-Molecular Sequence Data,
pubmed-meshheading:9556597-Mutagenesis, Site-Directed,
pubmed-meshheading:9556597-Recombinant Proteins,
pubmed-meshheading:9556597-Sequence Homology, Amino Acid,
pubmed-meshheading:9556597-Vascular Endothelial Growth Factor A,
pubmed-meshheading:9556597-Vascular Endothelial Growth Factors
|
pubmed:year |
1998
|
pubmed:articleTitle |
The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor.
|
pubmed:affiliation |
Institute of Molecular Medicine, Tumor Biology Center, D-79106 Freiburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|